Frontage Holdings Corporation (FGHQF)
OTCMKTS · Delayed Price · Currency is USD
0.1400
0.00 (0.00%)
At close: Feb 6, 2026
Frontage Holdings Market Cap
Frontage Holdings has a market cap or net worth of $280.13 million as of February 12, 2026. Its market cap has decreased by -36.58% in one year.
Market Cap
280.13M
Enterprise Value
385.87M
Revenue
253.01M
Ranking
n/a
PE Ratio
73.05
Stock Price
$0.14
Market Cap Chart
Since May 30, 2019, Frontage Holdings's market cap has decreased from 856.96M to 280.13M, a decrease of -67.31%. That is a compound annual growth rate of -15.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 280.13M | 7.53% |
| Dec 31, 2025 | 260.52M | -43.82% |
| Dec 31, 2024 | 463.74M | -23.13% |
| Dec 29, 2023 | 603.27M | -20.35% |
| Dec 30, 2022 | 757.40M | -27.11% |
| Dec 31, 2021 | 1.04B | -7.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 413.38M |
| CytoDyn | 304.50M |
| Silence Therapeutics | 213.03M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 113.23M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |